Medical Device User Fee Act; Public Meeting; Request for Comments; Amendment of Notice, 53702 [2010-21800]
Download as PDF
<![CDATA[
53702
Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices
Period of Replacement Award: The
period of support for the replacement
award is June 1, 2010 to October 31,
2010.
Authority: Section 330(h) of the Public
Health Service Act, 42 U.S.C. 245b.
CDFA Number: 93.703.
Justification for Exception to
Competition: The former grantee, Saint
Vincent’s Catholic Medical Centers of
New York, has relinquished all grants.
Saint Vincent’s Catholic Medical
Centers of New York’s inpatient services
has closed, and Saint Vincent’s Catholic
Medical Center of New York has filed
for bankruptcy under Chapter 11. The
former grantee has requested that HRSA
transfer the Health Center Program
Section 330(h) funds to SPHC in order
to implement and carry out grant
activities originally proposed under
SVCMC funded Section 330(h) grant
applications.
SPHC has been engaged in the
delivery of primary health care services
in the local area and is a current Section
330 grantee who indicated an ability to
assume operations without a disruption
of services.
The short-term transfer of the 330(h)
funds will ensure that critical primary
health care services continue and
remain available to low-income,
underserved, homeless patients with no
interruption in services to the target
population.
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2010–N–0389]
Medical Device User Fee Act; Public
Meeting; Request for Comments;
Amendment of Notice
hsrobinson on DSK69SOYB1PROD with NOTICES
Food and Drug Administration,
HHS.
Notice.
The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of a public
meeting on the reauthorization of the
medical device user fee program. This
meeting was announced in the Federal
SUMMARY:
18:24 Aug 31, 2010
BILLING CODE 4160–01–S
National Institute of Mental Health;
Amended Notice of Meeting
[FR Doc. 2010–21836 Filed 8–31–10; 8:45 am]
VerDate Mar<15>2010
[FR Doc. 2010–21800 Filed 8–31–10; 8:45 am]
National Institutes of Health
Dated: August 26, 2010.
Mary K. Wakefield,
Administrator.
ACTION:
Dated: August 27, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy,
Planning and Budget.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Marquita Cullom-Scott via e-mail at
MCullom-Scott@hrsa.gov or 301–594–
4300.
AGENCY:
Register of August 13, 2010 (75 FR
49502). The amendment is being made
to include the exact meeting location,
previously identified only as the
Washington D.C. metropolitan area.
There are no other changes.
FOR FURTHER INFORMATION CONTACT:
James Swink, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, rm. 1609, Silver Spring,
MD 20993, 301–796–6313, FAX: 301–
847–8121, email:
James.Swink@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of August 13, 2010 (75
FR 49502), FDA announced that a
public meeting on the reauthorization of
the medical device user fee program
would be held on September 14, 2010.
On page 49503, in the first column, the
Location portion of the document is
changed to read as follows:
Location: The meeting will be held at
the Marriott Inn and Conference Center,
University of Maryland University
College (UMUC), 3501 University Blvd.
East, Hyattsville, MD 20783,
www.marriott.com/wasum.
Jkt 220001
Notice is hereby given of a change in
the meeting of the Services
Subcommittee of the Interagency
Autism Coordinating Committee (IACC),
September 13, 2010, 1 p.m. to 4 p.m.,
National Institute of Mental Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A1/A2,
Rockville, MD 20852, which was
published in the Federal Register on
August 19, 2010, 75 FR 51276.
The meeting will not be Webcast as
originally advertised. The meeting is
open to the public and will still be
accessible through a conference call
phone number. The meeting will be
held in the same place and same time.
Dated: August 25, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21817 Filed 8–31–10; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Clinical Neuroscience
and Neurodegeneration Study Section,
September 30, 2010, 8 a.m. to October
1, 2010, 5 p.m., Washington Plaza Hotel,
10 Thomas Circle, NW., Washington,
DC, 20005 which was published in the
Federal Register on August 4, 2010, 75
FR 46950–46951.
The meeting will be one day only
September 30, 2010. The meeting time
and location remain the same. The
meeting is closed to the public.
Dated: August 26, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21816 Filed 8–31–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Developmental Biology.
Date: September 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Noni Byrnes, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892, (301) 435–
1023, byrnesn@csr.nih.gov.
E:\FR\FM\01SEN1.SGM
01SEN1
]]>Agencies
[Federal Register Volume 75, Number 169 (Wednesday, September 1, 2010)]
[Notices]
[Page 53702]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21800]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2010-N-0389]
Medical Device User Fee Act; Public Meeting; Request for
Comments; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of a public meeting on the reauthorization of
the medical device user fee program. This meeting was announced in the
Federal Register of August 13, 2010 (75 FR 49502). The amendment is
being made to include the exact meeting location, previously identified
only as the Washington D.C. metropolitan area. There are no other
changes.
FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993, 301-796-6313, FAX:
301-847-8121, email: James.Swink@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the Federal Register of August 13, 2010
(75 FR 49502), FDA announced that a public meeting on the
reauthorization of the medical device user fee program would be held on
September 14, 2010. On page 49503, in the first column, the Location
portion of the document is changed to read as follows:
Location: The meeting will be held at the Marriott Inn and
Conference Center, University of Maryland University College (UMUC),
3501 University Blvd. East, Hyattsville, MD 20783, www.marriott.com/wasum.
Dated: August 27, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-21800 Filed 8-31-10; 8:45 am]
BILLING CODE 4160-01-S
